Sustained complete remission of metastatic dermatofibrosarcoma protuberans with imatinib mesylate

SV Labropoulos, JA Fletcher, AM Oliveira… - Anti-cancer …, 2005 - journals.lww.com
Dermatofibrosarcoma protuberans (DFSP) is a soft tissue tumor which may recur locally and
rarely causes metastases to vital organs. DFSPs have specific chromosomal abnormalities …

Continuation of trastuzumab beyond disease progression is feasible and safe in patients with metastatic breast cancer: a retrospective analysis of 80 cases by the …

…, E Razis, D Tsavdaridis, M Karina, S Labropoulos… - Clinical breast …, 2003 - Elsevier
Despite the widespread use of trastuzumab in the management of patients with HER2-overexpressing
metastatic breast cancer, its optimal duration of administration is unknown. We …

Periodontal disease preceding osteonecrosis of the jaw (ONJ) in cancer patients receiving antiresorptives alone or combined with targeted therapies: report of 5 cases …

…, E Razis, D Galiti, E Galitis, S Labropoulos… - Oral Surgery, Oral …, 2015 - Elsevier
Objective We present clinical and radiologic data of periodontal tissue involvement preceding
the appearance of osteonecrosis of the jaw (ONJ) in 5 patients with solid tumors, who …

Imatinib in the treatment of dermatofibrosarcoma protuberans

SV Labropoulos, ED Razis - Biologics: Targets and Therapy, 2007 - Taylor & Francis
Dermatofibrosarcoma protuberans (DFSP) is a soft tissue tumor with tendency to recur
locally and only rarely metastasizes to vital organs. Surgery with wide margins remains the …

[HTML][HTML] Characterization of a novel large deletion and single point mutations in the BRCA1gene in a Greek cohort of families with suspected hereditary breast cancer

…, A Apessos, M Mihalatos, E Razi, S Labropoulos… - BMC cancer, 2004 - Springer
Background Germline mutations in BRCA1 and BRCA2 predispose to breast and ovarian
cancer. A multitude of mutations have been described and are found to be scattered …

[PDF][PDF] Osteonecrosis of the jaw in a patient with chronic myelogenous leukemia receiving imatinib-a case report with clinical implications

…, D Galiti, E Vardas, F Tzerbos, S Labropoulos - Forum Clin …, 2013 - researchgate.net
We present a case of osteonecrosis (2010) in a woman with chronic myelogenous leukemia
(CML) receiving imatinib (2008-present). Four years earlier (2005-2006) the patient …

[HTML][HTML] Is there an independent role of TERT and NF1 in high grade gliomas?

…, E Giannoulatou, I Tikas, SV Labropoulos… - Translational …, 2020 - Elsevier
BACKGROUND: High grade glioma molecular profiling is of particular interest in neurooncology.
The role of telomerase reverse transcriptase (TERT) varies dependent upon other …

Mutational and methylation analysis of the cyclin‐dependent kinase 4 inhibitor (p16INK4A) gene in chronic lymphocytic leukemia

P Tsirigotis, V Pappa, S Labropoulos… - European journal of …, 2006 - Wiley Online Library
Objectives: Chronic lymphocytic leukemia (CLL) comprises a heterogenous group of at least
two types of disease entities characterized by distinctive clinical, immunophenotypical and …

MBD2 contributes to developmental silencing of the human ε-globin gene

…, SZ Wang, M Gnanapragasam, S Labropoulos… - Blood Cells, Molecules …, 2011 - Elsevier
During erythroid development, the embryonic ε-globin gene becomes silenced as erythropoiesis
shifts from the yolk sac to the fetal liver where γ-globin gene expression predominates. …

Atypical femoral fractures (AFF) from bone remodeling agents in patients with cancer

…, L Hadjiyassemi, S Labropoulos… - Anticancer …, 2018 - ar.iiarjournals.org
Anti-resorptive drugs like bisphosphonates (BP) and denosumab are widely used for
prevention and treatment of skeletal diseases, such as osteoporosis and bone metastases and …